-
10m 39sPart 3 | Session 8 The Tailor-PCI Follow-up Study: Dr Naveen Pereira
-
9m 28sPart 3 | Session 9 Findings From the RESCUE Trial: Dr Paul M Ridker
-
15m 1sPart 3 | Session 10 The SAFE-PAD Study: Dr Eric Secemsky
-
11m 45sPart 3 | Session 11 Findings From the HOST-EXAM Trial: Dr Hyo-Soo Kim
-
15m 16sPart 3 | Session 12 Findings from the RAFT-AF Trial: Dr Anthony Tang
-
33m 28s
-
16m 3sPart 2 | Session 1 The Coalition ACTION Trial: Dr Harriette Van Spall & Dr Renato Lopes
-
16m 20sPart 2 | Session 2 The RADIANCE-HTN TRIO Trial: Dr Harriette Van Spall & Dr Ajay J Kirtane
-
15m 2sPart 2 | Session 3 The ISCHEMIA Trial: Dr Harriette Van Spall & Dr Gregg Stone
-
11m 30sPart 2 | Session 4 The LIFE Trial: Dr Harriette Van Spall & Dr Douglas L Mann
-
9m 1sPart 2 | Session 5 The STRENGTH Study: Dr Harriette Van Spall & Dr Steven E Nissen
-
16m 6s
-
11m 22sPart 3 | Session 1 Findings from the WASE COVID Study: Dr Frederico M Asch
-
12m 33sPart 3 | Session 2 The Prague OCHA Study: Dr Jan Belohlavek
-
7m 15sPart 3 | Session 3 The VOYAGER PAD Trial: Dr Rupert Bauersachs
-
8m 58sPart 3 | Session 4 30-day Results of the TRISCEND Study: Dr Susheel Kodali
-
10m 38sPart 3 | Session 5 The HOLIDAY Monitors Trial: Dr Gregory Marcus
-
Part 3 | Session 6 The CONNECT-HF Trial: Dr Adam DeVore
Our regular review series View from the Thoraxcenter hosted by Prof Nicolas Van Mieghem and Dr Joost Daemen (Thoraxcentre, Erasmus MC, Rotterdam, NL) provided a concise analysis of the late-breaking science results.
For a deeper dive into key randomized clinical trial data, Dr Harriette Van Spall (McMaster University, Hamilton, CA) interviewed principal investigators on their studies, learnings, and applicability to clinical practice in her regular Late-Breaker Discussion Series.
Short, accessible Expert Interviews were conducted with select faculty focusing on the results, applicability, and impact on future research.
The ACC. 21 Edition of Masterclass video highlighted the results of the ACC Survey on the hostile work environment.
More from this programme
Part 1
View from the Thoraxcenter: Wrap Up
Part 2
Late-breaker Discussion Series
Part 3
Expert Interviews
Part 4
Masterclass
Faculty Biographies
Mikhail Kosiborod
Cardiologist
Dr Mikhail Kosiborod is a cardiologist, the Vice President of Research at Saint Luke's Health System, and Professor of Medicine at the University of Missouri-Kansas City, US.
He is also Director of Cardiometabolic Research and Co-Director of the Saint Luke’s Michael & Marlys Haverty Cardiometabolic Center of Excellence at Saint Luke's Mid America Heart Institute. Dr Kosiborod is an internationally-recognised expert in the fields of diabetes and cardiovascular disease, cardiometabolic and cardiorenal syndromes.
Dr Kosiborod is involved in the leadership of numerous clinical trials and multi-center registries, and is currently the principal investigator of several investigator-initiated, multi-center trials in diabetes and cardiovascular disease.